43 research outputs found
Simulation-Based Assessment Methods
No full textThis chapter provides a brief overview of modelling and simulation approaches for smart grid systems. A special focus is put onto the coupling of simulation environments; i.e., the co-simulation of power systems and its components. Furthermore, selected implementations of standardized interfaces for domain simulators covering the domains of power systems and ICT are presented
Ethanol Electrooxidation at 1–2 nm AuPd Nanoparticles
No full textWe report a systematic study of the electrocatalytic properties and stability of a series of 1–2 nm Au, Pd, and AuPd alloy nanoparticles (NPs) for the ethanol oxidation reaction (EOR). Following EOR electrocatalysis, NP sizes and compositions were characterized using aberration-corrected scanning transmission electron microscopy (ac-STEM) and energy dispersive spectroscopy (EDS). Two main findings emerge from this study. First, alloyed AuPd NPs exhibit enhanced electrocatalytic EOR activity compared to either monometallic Au or Pd NPs. Specifically, NPs having a 3:1 ratio of Au:Pd exhibit an ~8-fold increase in peak current density compared to Pd NPs, with an onset potential shifted ~200 mV more to the negative compared to Au NPs. Second, the size and composition of AuPd alloy NPs do not (within experimental error) change following 1.0 or 2.0 h chronoamperometry experiments, while monometallic Au NPs increase in size from 2 to 5 nm under the same conditions. Notably, this report demonstrates the importance of post-catalytic ac-STEM/EDS characterization for fully evaluating NP activity and stability, especially for 1–2 nm NPs that may change in size or structure during electrocatalysis
Paper Biosensor for the Detection of NT-proBNP Using Silver Nanodisks as Electrochemical Labels
No full textWe report on the use of silver nanodisks (AgNDs), having a diameter of 50 ± 8 nm and a thickness of 8 ± 2 nm, as electrochemical labels for the detection of a model metalloimmunoassay for the heart failure biomarker NT-proBNP. The detection method is based on an electrochemically activated galvanic exchange (GE) followed by the detection of Ag using anodic stripping voltammetry (ASV). The AgNDs labels are superior to Ag nanocubes and Ag nanospheres in terms of the dynamic range for both the model and NT-proBNP metalloimmunoassays. The linear dynamic range for the model composite is 1.5 to 30.0 pM AgNDs. When AgND labels are used for the NT-proBNP assay, the dynamic range is 0.03–4.0 nM NT-proBNP. The latter range fully overlaps the risk stratification range for heart failure from 53 pM to 590 pM. The performance improvement of the AgNDs is a result of the specific GE mechanism for nanodisks. Specifically, GE is complete across the face of the AgNDs, leaving behind an incompletely exchanged ring structure composed of both Ag and Au
Revisiting the relativistic ejection event in XTE J1550-564 during the 1998 outburst
No full textWe revisit the discovery outburst of the X-ray transient XTE J1550−564 during which relativistic jets were observed in 1998 September, and review the radio images obtained with the Australian Long Baseline Array, and light curves obtained with the Molonglo Observatory Synthesis Telescope and the Australia Telescope Compact Array. Based on Hi spectra, we constrain the source distance to between 3.3 and 4.9 kpc. The radio images, taken some 2 d apart, show the evolution of an ejection event. The apparent separation velocity of the two outermost ejecta is at least 1.3c and may be as large as 1.9c; when relativistic effects are taken into account, the inferred true velocity is ≥ 0.8c. The flux densities appear to peak simultaneously during the outburst, with a rather flat (although still optically thin) spectral index of −0.2
Trim17, novel E3 ubiquitin-ligase, initiates neuronal apoptosis
No full textAccumulating data indicate that the ubiquitin-proteasome system controls apoptosis by regulating the level and the function of key regulatory proteins. In this study, we identified Trim17, a member of the TRIM/RBCC protein family, as one of the critical E3 ubiquitin ligases involved in the control of neuronal apoptosis upstream of mitochondria. We show that expression of Trim17 is increased both at the mRNA and protein level in several in vitro models of transcription-dependent neuronal apoptosis. Expression of Trim17 is controlled by the PI3K/Akt/GSK3 pathway in cerebellar granule neurons (CGN). Moreover, the Trim17 protein is expressed in vivo, in apoptotic neurons that naturally die during post-natal cerebellar development. Overexpression of active Trim17 in primary CGN was sufficient to induce the intrinsic pathway of apoptosis in survival conditions. This pro-apoptotic effect was abolished in Bax(-/-) neurons and depended on the E3 activity of Trim17 conferred by its RING domain. Furthermore, knock-down of endogenous Trim17 and overexpression of dominant-negative mutants of Trim17 blocked trophic factor withdrawal-induced apoptosis both in CGN and in sympathetic neurons. Collectively, our data are the first to assign a cellular function to Trim17 by showing that its E3 activity is both necessary and sufficient for the initiation of neuronal apoptosis. Cell Death and Differentiation (2010) 17, 1928-1941; doi: 10.1038/cdd.2010.73; published online 18 June 201
CO exposure, puff topography, and subjective effects in waterpipe tobacco smokers
No full textIntroduction: Waterpipe tobacco smoking is increasing in popularity though the toxicant exposure and effects associated with this tobacco use method are not well understood. Methods: Sixty-one waterpipe tobacco smokers (56 males; mean age ± SD, 30.9 ± 9.5 years; mean number of weekly waterpipe smoking episodes, 7.8 ± 5.7; mean duration of waterpipe smoking 8.5 ± 6.1 years) abstained from smoking for at least 24 hr and then smoked tobacco from a waterpipe ad libitum in a laboratory. Before and after smoking, expired-air carbon monoxide (CO) and subjective effects were assessed; puff topography was measured during smoking. Results: The mean waterpipe use episode duration was 33.1 ± 13.1 min. Expired-air CO increased significantly from a mean of 4.0 ± 1.7 before to 35.5 ± 32.7 after smoking. On average, participants took 169 ± 100 puffs, with a mean puff volume of 511 ± 333 ml. Urge to smoke, restlessness, craving, and other tobacco abstinence symptoms were reduced significantly after smoking, while ratings of dizzy, lightheaded, and other direct effects of nicotine increased. Discussion: Expired-air CO and puff topography data indicate that, relative to a single cigarette, a single waterpipe tobacco smoking episode is associated with greater smoke exposure. Abstinent waterpipe tobacco smokers report symptoms similar to those reported by abstinent cigarette smokers, and these symptoms are reduced by subsequent waterpipe tobacco smoking. Taken together, these data are consistent with the notion that waterpipe tobacco smoking is likely associated with the risk of tobacco-nicotine dependence. © The Author 2009. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. All rights reserved.Breland AB, 2006, NICOTINE TOB RES, V8, P727, DOI 10.1080-14622200600789585; Buchhalter AR, 2005, ADDICTION, V100, P550, DOI 10.1111-j.1360-0443.2005.01030.x; Cox L S, 2001, Nicotine Tob Res, V3, P7, DOI 10.1080-14622200020032051; Djordjevic MV, 2000, J NATL CANCER I, V92, P106, DOI 10.1093-jnci-92.2.106; Eissenberg T, 2008, J ADOLESCENT HEALTH, V42, P526, DOI 10.1016-j.jadohealth.2007.10.004; El-Nachef WN, 2008, JAMA-J AM MED ASSOC, V299, P36, DOI 10.1001-jama.2007.6; GROSS J, 1989, PSYCHOPHARMACOLOGY, V98, P334, DOI 10.1007-BF00451684; Hammal F, 2008, Tob Control, V17, pe3, DOI 10.1136-tc.2007.020529; HATSUKAMI DK, 1984, PSYCHOPHARMACOLOGY, V84, P231, DOI 10.1007-BF00427451; HUGHES JR, 1986, ARCH GEN PSYCHIAT, V43, P289; HUGHES JR, 1990, RES ADV ALCOHOL DRUG, V10, P317; Jackson D, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186-1471-2458-8-174; JOHN U, 2004, PREV MED, V38, P35; Kassel JD, 2007, J ADOLESCENT HEALTH, V40, P54, DOI 10.1016-j.jadohealth.2006.08.006; Kleykamp BA, 2008, EXP CLIN PSYCHOPHARM, V16, P99, DOI 10.1037-1064-1297.16.2.99; Knishkowy B, 2005, PEDIATRICS, V116, pE113, DOI 10.1542-peds.2004-2173; Maziak W, 2004, DRUG ALCOHOL DEPEN, V76, P101, DOI 10.1016-j.drugalcdep.2004.04.007; Maziak W, 2008, ADDICTION, V103, P1763, DOI 10.1111-j.1360-0443.2008.02327.x; Maziak W, 2004, TOB CONTROL, V13, P327, DOI 10.1136-tc.2004.008169; Maziak W, 2005, PHARMACOL BIOCHEM BE, V80, P173, DOI 10.1016-j.pbb.2004.10.026; Neergaard J, 2007, NICOTINE TOB RES, V9, P987, DOI 10.1080-14622200701591591; Salameh P, 2008, NICOTINE TOB RES, V10, P149, DOI 10.1080-14622200701767753; Saleh R, 2008, FOOD CHEM TOXICOL, V46, P1461, DOI 10.1016-j.fct.2007.12.007; Shafagoj YA, 2002, INT J CLIN PHARM TH, V40, P249; Shihadeh A, 2004, PHARMACOL BIOCHEM BE, V79, P75, DOI 10.1016-j.pbb.2004.06.005; Shihadeh A, 2003, FOOD CHEM TOXICOL, V41, P143, DOI 10.1016-S0278-6915(02)00220-X; Shihadeh A, 2005, BEHAV RES METHODS, V37, P186, DOI 10.3758-BF03206414; Smith-Simone S, 2008, NICOTINE TOB RES, V10, P393, DOI 10.1080-14622200701825023; Strasser AA, 2004, CANCER EPIDEM BIOMAR, V13, P1800; Ward KD, 2005, NICOTINE TOB RES, V7, P149, DOI 10.1080-14622200412331328402; World Health Organization, 2005, TOBREG ADV NOT WAT T; ZACNY JP, 1988, J PHARMACOL EXP THER, V246, P61957585
Final results of the telaprevir access program: Fibroscan values predict safety and efficacy in hepatitis c patients with advanced fibrosis or cirrhosis
No full textBackground: Liver stiffness determined by transient elastography is correlated with hepatic fibrosis stage and has high accuracy for detecting severe fibrosis and cirrhosis in chronic hepatitis C patients. We evaluated the clinical value of baseline FibroScan values for the prediction of safety and efficacy of telaprevir-based therapy in patients with advanced fibrosis and cirrhosis in the telaprevir Early Access Program HEP3002. Methods: 1,772 patients with HCV-1 and bridging fibrosis or cirrhosis were treated with telaprevir plus pegylated interferon-α and ribavirin (PR) for 12 weeks followed by PR alone, the total treatment duration depending on virological response and previous response type. Liver fibrosis stage was determined either by liver biopsy or by non-invasive markers. 1,282 patients (72%) had disease stage assessed by FibroScan; among those 46% were classified as Metavir F3 at baseline and 54% as F4. Results: Overall, 1,139 patients (64%) achieved a sustained virological response (SVR) by intentionto- treat analysis. Baseline FibroScan values were tested for association with SVR and the occurrence of adverse events. By univariate analysis, higher baseline FibroScan values were predictive of lower sustained virological response rates and treatment-related anemia. By multivariate analysis, FibroScan was no longer statistically significant as an independent predictor, but higher FibroScan values were correlated with the occurrence of infections and serious adverse events. Conclusions: FibroScan has a limited utility as a predictor of safety and efficacy in patients treated with telaprevir-based triple therapy. Nevertheless it can be used in association with other clinical and biological parameters to help determine patients who will benefit from the triple regiments. © 2015 Lepida et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Author Correction: Microbial temperature sensitivity and biomass change explain soil carbon loss with warming
No full textVerbesserung der Wundheilung durch wassergefiltertes Infrarot A (wIRA) bei Patienten mit chronischen venösen Unterschenkel-Ulzera einschließlich infrarot-thermographischer Beurteilung
No full textBackground: Water-filtered infrared-A (wIRA) is a special form of heat radiation with a high tissue-penetration and with a low thermal burden to the surface of the skin. wIRA is able to improve essential and energetically meaningful factors of wound healing by thermal and non-thermal effects.
Aim of the study: prospective study (primarily planned randomised, controlled, blinded, de facto with one exception only one cohort possible) using wIRA in the treatment of patients with recalcitrant chronic venous stasis ulcers of the lower legs with thermographic follow-up.
Methods: 10 patients (5 males, 5 females, median age 62 years) with 11 recalcitrant chronic venous stasis ulcers of the lower legs were treated with water-filtered infrared-A and visible light irradiation (wIRA(+VIS), Hydrosun® radiator type 501, 10 mm water cuvette, water-filtered spectrum 550–1400 nm) or visible light irradiation (VIS; only possible in one patient). The uncovered wounds of the patients were irradiated two to five times per week for 30 minutes at a standard distance of 25 cm (approximately 140 mW/cm2 wIRA and approximately 45 mW/cm2 VIS). Treatment continued for a period of up to 2 months (typically until closure or nearly closure of the ulcer). The main variable of interest was “percent change of ulcer size over time” including complete wound closure. Additional variables of interest were thermographic image analysis, patient’s feeling of pain in the wound, amount of pain medication, assessment of the effect of the irradiation (by patient and by clinical investigator), assessment of feeling of the wound area (by patient), assessment of wound healing (by clinical investigator) and assessment of the cosmetic state (by patient and by clinical investigator). For these assessments visual analogue scales (VAS) were used.
Results: The study showed a complete or nearly complete healing of lower leg ulcers in 7 patients and a clear reduction of ulcer size in another 2 of 10 patients, a clear reduction of pain and pain medication consumption (e.g. from 15 to 0 pain tablets per day), and a normalization of the thermographic image (before the beginning of the therapy typically hyperthermic rim of the ulcer with relative hypothermic ulcer base, up to 4.5°C temperature difference). In one patient the therapy of an ulcer of one leg was performed with the fully active radiator (wIRA(+VIS)), while the therapy of an ulcer of the other leg was made with a control group radiator (only VIS without wIRA), showing a clear difference in favour of the wIRA treatment. All mentioned VAS ratings improved remarkably during the period of irradiation treatment, representing an increased quality of life. Failures of complete or nearly complete wound healing were seen only in patients with arterial insufficiency, in smokers or in patients who did not have venous compression garment therapy.
Discussion and conclusions: wIRA can alleviate pain considerably (with an impressive decrease of the consumption of analgesics) and accelerate wound healing or improve a stagnating wound healing process and diminish an elevated wound exudation and inflammation both in acute and in chronic wounds (in this study shown in chronic venous stasis ulcers of the lower legs) and in problem wounds including infected wounds. In chronic recalcitrant wounds complete healing is achieved, which was not reached before. Other studies have shown that even without a disturbance of wound healing an acute wound healing process can be improved (e.g. reduced pain) by wIRA.
wIRA is a contact-free, easily used and pleasantly felt procedure without consumption of material with a good penetration effect, which is similar to solar heat radiation on the surface of the earth in moderate climatic zones. Wound healing and infection defence (e.g. granulocyte function including antibacterial oxygen radical formation of the granulocytes) are critically dependent on a sufficient energy supply (and on sufficient oxygen). The good clinical effect of wIRA on wounds and also on problem wounds and wound infections can be explained by the improvement of both the energy supply and the oxygen supply (e.g. for the granulocyte function). wIRA causes as a thermal effect in the tissue an improvement in three decisive factors: tissue oxygen partial pressure, tissue temperature and tissue blood flow. Besides this non-thermal effects of infrared-A by direct stimulation of cells and cellular structures with reactions of the cells have also been described. It is concluded that wIRA can be used to improve wound healing, to reduce pain, exudation, and inflammation and to increase quality of life.Hintergrund: Wassergefiltertes Infrarot A (wIRA) ist eine spezielle Form der Wärmestrahlung mit hoher Gewebepenetration bei geringer thermischer Oberflächenbelastung. wIRA vermag über thermische und nicht-thermische Effekte wesentliche und energetisch bedeutsame Faktoren der Wundheilung zu verbessern.
Ziel der Studie: prospektive Studie (primär randomisiert, kontrolliert, verblindet geplant, de facto mit einer Ausnahme nur eine Kohorte möglich) mit wassergefiltertem Infrarot A (wIRA) in der Therapie von Patienten mit therapierefraktären chronischen venösen Unterschenkel-Ulzera mit thermographischer Verlaufskontrolle.
Methoden: 10 Patienten (5 Männer, 5 Frauen, Median des Alters 62 Jahre) mit 11 therapierefraktären chronischen venösen Unterschenkel-Ulzera wurden mit wassergefiltertem Infrarot A und sichtbarem Licht (wIRA(+VIS), Hydrosun®-Strahler Typ 501, 10 mm Wasserküvette, wassergefiltertes Spektrum 550–1400 nm) oder mit sichtbarem Licht (VIS; nur bei einem Patienten möglich) bestrahlt. Die unbedeckten Wunden der Patienten wurden zwei- bis fünfmal pro Woche über bis zu 2 Monate (typischerweise bis zum Wundschluss oder Fast-Wundschluss des Ulkus) für jeweils 30 Minuten mit einem Standardabstand von 25 cm bestrahlt (ungefähr 140 mW/cm2 wIRA und ungefähr 45 mW/cm2 VIS). Hauptzielvariable war die „prozentuale Änderung der Ulkusgröße über die Zeit“ einschließlich des kompletten Wundschlusses. Zusätzliche Zielvariablen waren thermographische Bildanalyse, Schmerzempfinden des Patienten in der Wunde, Schmerzmittelverbrauch, Einschätzung des Effekts der Bestrahlung (durch Patient und durch klinischen Untersucher), Einschätzung des Patienten des Gefühls im Wundbereich, Einschätzung der Wundheilung durch den klinischen Untersucher sowie Einschätzung des kosmetischen Zustandes (durch Patienten und durch klinischen Untersucher). Für diese Erhebungen wurden visuelle Analogskalen (VAS) verwendet.
Ergebnisse: Die Studie ergab eine vollständige oder fast vollständige Abheilung der Unterschenkel-Ulzera bei 7 Patienten sowie eine deutliche Ulkusverkleinerung bei 2 weiteren der 10 Patienten, eine bemerkenswerte Minderung der Schmerzen und des Schmerzmittelverbrauchs (von z.B. 15 auf 0 Schmerztabletten täglich) und eine Normalisierung des thermographischen Bildes (vor Therapiebeginn typischerweise hyperthermer Ulkusrandwall mit relativ hypothermem Ulkusgrund, bis zu 4,5°C Temperaturdifferenz). Bei einem Patienten wurde ein Ulkus an einem Bein mit dem Vollwirkstrahler (wIRA(+VIS)) therapiert, während ein Ulkus am anderen Bein mit einem Kontrollgruppenstrahler (nur VIS, ohne wIRA) behandelt wurde, was einen deutlichen Unterschied zugunsten der wIRA-Therapie zeigte. Alle aufgeführten VAS-Einschätzungen verbesserten sich während der Bestrahlungstherapie-Periode sehr stark, was einer verbesserten Lebensqualität entsprach. Ein kompletter oder fast kompletter Wundschluss wurde nur bei Patienten mit peripherer arterieller Verschlusskrankheit, Rauchern oder Patienten mit fehlender venöser Kompressionstherapie nicht erreicht.
Diskussion und Schlussfolgerungen: wIRA kann sowohl bei akuten Wunden als auch bei chronischen Wunden (in dieser Studie für chronische venöse Unterschenkelulzera gezeigt) und Problemwunden einschließlich infizierter Wunden Schmerzen deutlich mindern (mit eindrucksvoller Abnahme des Schmerzmittelverbrauchs) und die Wundheilung beschleunigen oder einen stagnierenden Wundheilungsprozess verbessern sowie eine erhöhte Wundsekretion und Entzündung mindern.
Bei chronischen therapierefraktären Wunden werden vollständige Abheilungen erreicht, die zuvor nicht erreicht wurden. Andere Studien haben sogar ohne Wundheilungsstörung eine Verbesserung (z.B. Schmerzreduktion) der akuten Wundheilung durch wIRA gezeigt.
wIRA ist ein kontaktfreies, verbrauchsmaterialfreies, leicht anzuwendendes, als angenehm empfundenes Verfahren mit guter Tiefenwirkung, das der Sonnenwärmestrahlung auf der Erdoberfläche in gemäßigten Klimazonen nachempfunden ist.
Wundheilung und Infektionsabwehr (z.B. Granulozytenfunktion einschließlich antibakterieller Sauerstoffradikalbildung der Granulozyten) hängen ganz entscheidend von einer ausreichenden Energieversorgung (und von ausreichend Sauerstoff) ab. Die gute klinische Wirkung von wIRA auf Wunden und auch auf Problemwunden und Wundinfektionen lässt sich über die Verbesserung sowohl der Energiebereitstellung als auch der Sauerstoffversorgung (z.B. für die Granulozytenfunktion) erklären. wIRA bewirkt als thermischen Effekt im Gewebe eine Verbesserung von drei entscheidenden Faktoren: Sauerstoffpartialdruck im Gewebe, Gewebetemperatur und Gewebedurchblutung. Daneben wurden auch nicht-thermische Effekte von Infrarot A durch direkte Reizsetzung auf Zellen und zelluläre Strukturen mit Reaktionen der Zellen beschrieben.
Es wird geschlossen, dass wIRA verwendet werden kann, um Wundheilung zu verbessern, Schmerzen, Sekretion und Entzündung zu reduzieren und die Lebensqualität zu steigern
Protection of the European Union’s Public (Financial) Interest in Normative Budgetary Principles
No full textThe problems concerning the protection of the EU financial interest are generally discussed in the context of fighting corruption or preventing and eliminating fraud (financial irregularities). In many cases, the actions taken have ex-post character since they concern situations of inappropriate distribution (allocation) of public funds. In this article, the Author approached these problematics a bit differently because he tried to prove that already on the stage of planning (constructing) EU budget as well as during its implementation there are instruments such as normative budgetary principles which may serve to protect its financial interest ex-ante. Moreover, the primary sources of this protection should be also found in the public choice theory, functioning in the economics. Therefore, the aim of this article is to prove the following hypotheses: the basis for protection of the EU financial interest is to be found in the functioning public choice theory as well as in – being its consequence – normative budgetary principles, whose content includes duty to properly govern, and especially plan, public funds accumulated in the EU budget. Conclusions resulting from the analysis of the indicated problematics have been determined on the basis of non-reactive (non-empirical) research methods, i.e. examination of the reference literature and binding EU [email protected] of Financial Law, Department of Public Finance and Financial Law, Faculty of Law, University of Bialystok, Poland. The Author specializes in local government finance, EU public finance, and public debt management. He is a member of the Regional Chamber of Account in Bialystok and the Center for Information and Research Organization in Public Finance and Tax Law of Central and Eastern Europe.University of BialystokAustin, A.D.: Present Trends and the Evolution of Mandatory Spending, Congressional Research Service Report, 2017. www.everycrsreport.com.Buchanan, J.M., Musgrave, R.A.: Public Finance and Public Choice, Two Contrasting Visions of the State, Cambridge: Massachusetts Institute of Technology, 2001.Buchanan, J.M.: Public finance in the democratic process: Fiscal institutions and individual choice, Chapell Hill: University of North Carolina Press, 1987.Eklund, R.B., Hebert, R.F.: A History of Economic Theory and Method, Long Grove, IL: Waveland Press, 2014.European Commission: EU Budget 2016. Financial report, Luxembourg: Publications Office of the European Union, 2017. www.ec.europa.eu.European Commission: Report from the Commission to the European Parliament and the Council. Protection of the European Union’s financial interests. Fight against fraud 2016 Annual Report, Brussels: European Union, 2016. www.ec.europa.eu.European Commission: European Union Public Finance, Luxembourg: Publication Office of the European Union, 2008.European Commission: European Union Public Finance, Luxembourg: Publication Office of the European Union, 2014.Etel, L., Tyniewicki, M. (eds.): Finanse publiczne i prawo finansowe. Realia i perspektywy zmian (Public finance and financial law. Realities and perspectives of changes), Bialystok: Temida 2, 2012.Gaudemet, P.M., Molinier, J.: Finanse publiczne (Public finance), Warszawa: PWE, 2000.Kiefer, D.: Macroeconomic policy and public choice, Berlin: Springer, 1999.Kosikowski, C.: Financial Law of the European Union, Bialystok: Temida 2, 2008.Lenaerts, K., Van Nuffel, P.: European Union Law, London: Sweet & Maxwell, 2011.Lee, D.R.: Public Choice, Past, and Present. The Legacy of James M. Buchanan and Gordon Tullock, New York: Springer New York, 2013.Mukherjee, S.: Modern economic theory, New Delhi: New Age International, 2005.Moe, T.M.: The New Economics of Organization, American Journal of Political Science no. 28 (1984).Musgrave, R.A., Musgrave, P.B.: Public Finance in Theory and Practice, India: McGraw-Hill Education, 1989.Owsiak, S.: Finanse publiczne. Teoria i praktyka (Public finance. Theory and practice), Warszawa: PWN, 1998.Report from the Commission to the European Parliament and the Council. Protection of the European Union’s financial interests. Fight against fraud 2016 Annual Report, Brussels: European Union, 2016. www.ec.europa.eu.Ruśkowski, E. (eds.): Roczność i wieloletniość w finansach publicznych (Annuality and mutliannuality in public finance), Warszawa: Lex a Wolters Kluwer business, 2014.Salachna, J.M., Tyniewicki, M.: Communication and the financial decisions made by public authorities, Prawo Budżetowe Państwa i Samorządu (Budget Law of the State and Local Governments) no. 4(5) (2017).Salachna, J.M., Tyniewicki, M.: Moralność jako element podejmowania decyzji finansowych w sektorze publicznym (Morality as a factor in financial decisions making within the public sector), Prawo Budżetowe Państwa i Samorządu (Budget Law of the State and Local Governments) no. 3(4) (2016).Strasser, D.: The Finances of Europe, Luxembourg: Office for Official Publications of the European Communities, 1992.Szarek-Mason, P.: The European Union’s Fights Against Corruption. The Evolving Policy Towards the Member States and Candidate Countries, New York: Cambridge University Press, 2010.Stiglitz, J.E.: Economics of the public sector, New York: Norton, 2000.Weingast, B.R., Moran, M.: The Congressional-Bureaucratic System: A Principal-Agent Perspective, Public Choice no. 44 (1984).White, S.: Protection of the Financial Interests of the European Communities: The Fight against Fraud and Corruption, Hague: Kluwer Law International, 1998.EU: Treaty on the Functioning of the European Union: no. 2012/C 326/01.EU: Regulation of the European Parliament and the Council (EC, Euratom): no. 966/2012 on the financial rules applicable to the general budget of the Union and repealing Council Regulation (EC, Euratom) no. 1605/2002.EU: Council Decision: no. 2014/335/EU on the system of own resources of the EU (OJ 2014/L168/105).13114
